Europe Plasma Fractionation Market – Industry Trends and Forecast to 2028

  • Healthcare
  • Published Report
  • Jul 2021
  • Europe
  • 350 Pages
  • No of Tables: 117
  • No of Figures: 43

Europe Plasma Fractionation Market, By Product Type (Immunoglobulins, Coagulation Factor Concentrates, Albumin, Protease Inhibitors and Other Products), Application (Neurology, Immunology, Hematology, Critical Care, Pulmonology, Hemato- Oncology, Rheumatology and Others),  Processing Technology (Ion- Exchange Chromatography , Affinity Chromatography, Cryopreservation, Ultrafiltration and Microfiltration), Mode (Modern Plasma Fractionation and Traditional Plasma Fractionation), End User (Hospitals & Clinics, Clinical Research Laboratories Academic Institutions and Others), Distribution Channel (Direct Tenders, Third Party Distribution and Others) , Country (Germany, U.K., Italy, France, Spain, Switzerland, Netherlands, Russia, Turkey, and Rest of Europe) Industry Trends and Forecast to 2028.

Europe Plasma Fractionation Market Market Analysis and Insights: Europe Plasma Fractionation Market

Europe plasma fractionation market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 5.9% in the forecast period of 2021 to 2028 and is expected to reach USD 2,423.33 million by 2028. High presence of number of plasma collection centres are helping in growing demand of the plasma fractionation market.

Plasma is a blood component that derives from whole blood by plasmapheresis and is used for various therapeutic and medical applications. Human plasma is s source of numerous different proteins. However, only few of these proteins are useful for producing therapeutic plasma products. The process of separation, extraction and purification of these proteins from the plasma is called fractionation process.

Europe plasma fractionation market is growing with factors such as rise in respiratory diseases across the world, increase in aging population with blood-related ailments and increasing usage of immunoglobulins. Increase in rare diseases that require the use of plasma therapy or plasma derivatives also acts as a major factor for the growth of the market. Increasing investment in research and development has also given a boom to the Europe plasma fractionation market.

However, the stringent government regulations regarding the plasma therapies are restraining the growth of plasma fractionation market. Additionally, the shortage of plasma proteins acts as a hindrance towards the growth of the market.

This plasma fractionation market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Europe Plasma Fractionation Market Europe Plasma Fractionation Market Scope and Market Size

Europe plasma fractionation market is segmented into six notable segments which are based on the product type, application, processing technology, mode, end user and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of product type, the plasma fractionation market is segmented into immunoglobulins, coagulation factor concentrate, albumin, protease inhibitors and other products. In 2021, immunoglobulin has the largest market share owing to the factors that they can be used in the treatment of immunodeficiency and auto immune disorders treatments.
  • On the basis of application, the plasma fractionation market is segmented into neurology, immunology, haematology, critical care, pulmonology, hemato- oncology, rheumatology and others. In 2021, immunology has the largest market share owing to the factors increasing in the incidences of immunology disorders among the patients.
  • On the basis of processing technology, the plasma fractionation market is segmented into Ion- exchange chromatography, affinity chromatography, cryopreservation, ultrafiltration and microfiltration. In 2021, Ion- exchange chromatography has the largest market share owing to the factor such as the increasing efficiency by using ionic substances and charged molecules.
  • On the basis of mode, the plasma fractionation market is segmented into modern plasma fraction and traditional plasma fractionation. In 2021, modern plasma fractions have the largest market share owing to the factors such as the adopting new equipment and techniques for the plasma fractionation process.
  • On the basis of end user, the plasma fractionation market is segmented into Hospitals & clinics, clinical research laboratories academic institutions and others. In 2021, hospitals & clinics has the largest market share due to increase in the emergency cases where the patients need to be treated effective and permanently.
  • On the basis of distribution channel, the plasma fractionation market is segmented into direct tenders, third party distribution and others. In 2021, direct tenders have the largest market share due to the ease if distribution of the plasma products with a lot of consumer interest.

Europe Plasma Fractionation Market: Country Level Analysis

Europe plasma fractionation market is analysed and market size information is provided by country, product type, application, processing technology, mode, end user and distribution channel as referenced above.

The countries covered in the Europe plasma fractionation market report are Germany, France, U.K., Italy, Spain, Russia, Turkey, Netherlands, Switzerland and rest of Europe.

Germany is dominating in the Europe plasma fractionation market with the highest CAGR due to increase in the demand for plasma fractionation and growing concern over the human health.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Europe brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Rising Demand of Plasma Fractionation

Europe plasma fractionation market also provides you with detailed market analysis for every country growth in industry with sales, components sales, impact of technological development in plasma fractionation and changes in regulatory scenarios with their support for the plasma fractionation product market. The data is available for historic period 2010-2019.

Competitive Landscape and Europe Plasma Fractionation Market Share Analysis

Europe plasma fractionation market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, India presence, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to Europe plasma fractionation market.

Some of the major players operating in the plasma fractionation market are Grifols, S.A., Takeda Pharmaceutical Company Limited, Octapharma AG, CSL Plasma, LFB SA, Green Cross Corp., Baxter, Bio Products Laboratory Ltd., Novasep Holding SAS, Pall Corporation, Bharat Serums and Vaccines Limited (BSV), Kedrion S.p.A, Sanquin, Biotest AG, Merck KGaA, ADMA Biologics, Inc., Boccard, Intas Pharmaceuticals Ltd. and CENTURION İlaç Sanayi ve Ticaret A.Ş. among others. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many product launches are also initiated by the companies worldwide which are also accelerating the growth of Europe plasma fractionation market.

For instance,

  • In April 2020, Grifols launched 3- ml vial for Hyper RAB which is rabies immune globulin in the plasma fractionation market to help in the treatment of rabies cases across the world.

Collaboration, joint ventures and other strategies by the market players is enhancing the company footprints in the Plasma Fractionation market which also provides the benefit for organisation in its growth pace.

Customization Available: Europe Plasma Fractionation Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.


SKU-

TABLE 1 EUROPE PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 2 EUROPE IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 3 EUROPE IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 4 EUROPE COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 5 EUROPE COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 6 EUROPE ALBUMIN IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 7 EUROPE PROTEASE INHIBITORS IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 8 EUROPE OTHER PRODUCTS IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 9 EUROPE PLASMA FRACTIONATION MARKET, APPLICATION, 2019-2028 (USD MILLION)

TABLE 10 EUROPE IMMUNOLOGY IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 11 EUROPE HAEMATOLOGY IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 12 EUROPE CRITICAL CARE IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 13 EUROPE NEUROLOGY IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 14 EUROPE PULMONOLOGY IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 15 EUROPE HAEMATO-ONCOLOGY IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 16 EUROPE RHEUMATOLOGY IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 17 EUROPE OTHER APPLICATION IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 18 EUROPE PLASMA FRACTIONATION MARKET, PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 19 EUROPE ION-EXCHANGE CHROMATOGRAPHY IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 20 EUROPE AFFINITY CHROMATOGRAPHY IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 21 EUROPE ULTRAFILTRATION IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 22 EUROPE MICROFILTRATION IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 23 EUROPE CRYOPRECIPITATION IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 24 EUROPE PLASMA FRACTIONATION MARKET, MODE, 2019-2028 (USD MILLION)

TABLE 25 EUROPE MODERN PLASMA FRACTIONATION IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 26 EUROPE TRADITIONAL PLASMA FRACTIONATION IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 27 EUROPE PLASMA FRACTIONATION MARKET, END USER, 2019-2028 (USD MILLION)

TABLE 28 EUROPE HOSPITALS & CLINICS IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 29 EUROPE CLINICAL RESEARCH LABORATORIES IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 30 EUROPE ACADEMIC INSTITUTES IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 31 EUROPE OTHERS IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 32 EUROPE PLASMA FRACTIONATION MARKET, DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 33 EUROPE DIRECT TENDERS IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 34 EUROPE THIRD PARTY DISTRIBUTION IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 35 EUROPE OTHERS IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 36 EUROPE PLASMA FRACTIONATION MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 37 EUROPE PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 38 EUROPE IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 39 EUROPE COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 40 EUROPE PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 41 EUROPE PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 42 EUROPE PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 43 EUROPE PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 44 EUROPE PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 45 GERMANY PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 46 GERMANY IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 47 GERMANY COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 48 GERMANY PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 49 GERMANY PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 50 GERMANY PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 51 GERMANY PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 52 GERMANY PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 53 FRANCE PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 54 FRANCE IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 55 FRANCE COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 56 FRANCE PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 57 FRANCE PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 58 FRANCE PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 59 FRANCE PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 60 FRANCE PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 61 U.K. PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 62 U.K. IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 63 U.K. COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 64 U.K. PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 65 U.K. PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 66 U.K. PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 67 U.K. PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 68 U.K. PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 69 ITALY PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 70 ITALY IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 71 ITALY COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 72 ITALY PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 73 ITALY PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 74 ITALY PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 75 ITALY PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 76 ITALY PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 77 SPAIN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 78 SPAIN IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 79 SPAIN COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 80 SPAIN PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 81 SPAIN PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 82 SPAIN PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 83 SPAIN PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 84 SPAIN PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 85 RUSSIA PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 86 RUSSIA IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 87 RUSSIA COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 88 RUSSIA PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 89 RUSSIA PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 90 RUSSIA PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 91 RUSSIA PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 92 RUSSIA PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 93 TURKEY PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 94 TURKEY IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 95 TURKEY COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 96 TURKEY PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 97 TURKEY PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 98 TURKEY PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 99 TURKEY PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 100 TURKEY PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 101 NETHERLANDS PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 102 NETHERLANDS IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 103 NETHERLANDS COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 104 NETHERLANDS PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 105 NETHERLANDS PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 106 NETHERLANDS PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 107 NETHERLANDS PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 108 NETHERLANDS PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 109 SWITZERLAND PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 110 SWITZERLAND IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 111 SWITZERLAND COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 112 SWITZERLAND PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 113 SWITZERLAND PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 114 SWITZERLAND PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 115 SWITZERLAND PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 116 SWITZERLAND PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 117 REST OF EUROPE PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions